Consensus ABIONYX Pharma

Equities

ABNX

FR0012616852

Market Closed - Euronext Paris Other stock markets 11:35:09 2024-06-04 am EDT			5-day change	1st Jan Change
1.248 ^EUR	0.00%		+0.48%	-3.11%

Mar. 14	Abionyx Pharma: to benefit from a 1ME grant from Bpifrance	CF
Mar. 11	Abionyx: reduced net loss in 2023	CF

Evolution of the average Target Price on ABIONYX Pharma

Price target over the last 5 years

History of analyst recommendation changes

6f6412146fdd4dbacbe262f03cf1.m7z_7XyAd38-FF8qVpKGQOx-ouA4CGhBMA0VRPi6TUU.q-iajxDoLUt9JRxhZsPyF5UzzaQMOC0YSnpdIoHbFwz0_pa9LMEkUndYDg~5b71551c4dcd1f294c50da641ca01971

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.248 EUR

Average target price

10.5 EUR

Spread / Average Target

+741.35%

High Price Target

10.5 EUR

Spread / Highest target

+741.35%

Low Price Target

10.5 EUR

Spread / Lowest Target

+741.35%

Consensus detail

Consensus revision (last 18 months)

Ratings for ABIONYX Pharma

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar